DBV Technologies (DBVT) Enterprise Value Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.03% |
| Dec 31, 2025 | 2.45% |
| Sep 30, 2025 | 31.01% |
| Jun 30, 2025 | 25.34% |
| Mar 31, 2025 | 44.07% |
| Dec 31, 2024 | 25.12% |
| Sep 30, 2024 | 22.11% |
| Jun 30, 2024 | 19.20% |
| Mar 31, 2024 | 12.67% |
| Dec 31, 2023 | 10.37% |
| Sep 30, 2023 | 12.34% |
| Jun 30, 2023 | 11.24% |
| Mar 31, 2023 | 12.54% |
| Dec 31, 2022 | -3.18% |
| Sep 30, 2022 | -15.90% |
| Jun 30, 2022 | -27.19% |
| Dec 31, 2021 | 17.99% |
| Sep 30, 2021 | 15.08% |
| Jun 30, 2021 | 8.63% |
| Dec 31, 2020 | -6.54% |
| Jun 30, 2020 | -4.43% |
| Dec 31, 2019 | 11.74% |
| Jun 30, 2019 | 28.25% |
| Dec 31, 2018 | 26.61% |
| Jun 30, 2018 | -12.51% |
| Dec 31, 2017 | -4.28% |